224 related articles for article (PubMed ID: 37072474)
1. Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma.
Zhu QY
Sci Rep; 2023 Apr; 13(1):6310. PubMed ID: 37072474
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the molecular mechanisms, shared gene signatures, and MicroRNAs between systemic lupus erythematosus and diffuse large B cell lymphoma by bioinformatics analysis.
Peng Z; Liang X; Lin X; Lin W; Lin Z; Wei S
Lupus; 2022 Oct; 31(11):1317-1327. PubMed ID: 35817571
[TBL] [Abstract][Full Text] [Related]
3. Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma.
Li H; Zhou J; Zhou L; Zhang X; Shang J; Feng X; Yu L; Fan J; Ren J; Zhang R; Duan X
J Gene Med; 2023 Dec; 25(12):e3558. PubMed ID: 37392050
[TBL] [Abstract][Full Text] [Related]
4. Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
Afrasiabi A; Keane JT; Ong LTC; Alinejad-Rokny H; Fewings NL; Booth DR; Parnell GP; Swaminathan S
J Autoimmun; 2022 Feb; 127():102781. PubMed ID: 34952359
[TBL] [Abstract][Full Text] [Related]
5. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
6. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
9. Aggressive large B-cell lymphoma in a systemic lupus erythematosus patient with chronic active Epstein-Barr virus infection: a case report.
Abenavoli L; Pennacchia I; Stigliano E; Carbone A; Vecchio FM; Arena V
Int J Immunopathol Pharmacol; 2011; 24(4):1083-6. PubMed ID: 22230415
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
11. Exploration and analysis of differentially expressed genes in Epstein-Barr virus negative and positive plasmablastic lymphoma.
Liang Y; Wang H; Luo B
Clin Transl Oncol; 2023 Oct; 25(10):2884-2891. PubMed ID: 36991219
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics identification of key candidate genes and pathways associated with systemic lupus erythematosus.
Yang F; Zhai Z; Luo X; Luo G; Zhuang L; Zhang Y; Li Y; Sun E; He Y
Clin Rheumatol; 2020 Feb; 39(2):425-434. PubMed ID: 31673979
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.
Wang XN; Hong J; Xu YG; Zhang P; Li YY; Dou HL; Li HP
BMC Ophthalmol; 2024 Mar; 24(1):99. PubMed ID: 38438866
[TBL] [Abstract][Full Text] [Related]
17. The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.
Healy JA; Dave SS
Curr Top Microbiol Immunol; 2015; 390(Pt 1):315-37. PubMed ID: 26424652
[TBL] [Abstract][Full Text] [Related]
18. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of EBV associated diffuse large B-cell lymphoma.
Frontzek F; Staiger AM; Wullenkord R; Grau M; Zapukhlyak M; Kurz KS; Horn H; Erdmann T; Fend F; Richter J; Klapper W; Lenz P; Hailfinger S; Tasidou A; Trautmann M; Hartmann W; Rosenwald A; Quintanilla-Martinez L; Ott G; Anagnostopoulos I; Lenz G
Leukemia; 2023 Mar; 37(3):670-679. PubMed ID: 36604606
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update.
Hong JY; Ko YH; Kim SJ; Kim WS
Curr Opin Oncol; 2015 Sep; 27(5):392-8. PubMed ID: 26258272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
